Skip to main content

Alnylam Touts Advances with Lipid, Conjugate Delivery Technologies

Premium

Alnylam Pharmaceuticals said this week that it and collaborators have developed a novel class of lipid nanoparticles capable of greater target inhibition than the company's existing lipid delivery agents.

According to the company, the so-called reLNPs demonstrate “potent target gene silencing in vivo, with an ED50 at doses of less than 0.05 mg/kg while demonstrating tolerability at doses exceeding 10 mg/kg.”

This represents a roughly 10-fold improvement over the company's second-generation MC3 lipids, and an approximately 100-fold increase in efficacy over first-generation technologies.

The MC3 lipid is currently at issue in a lawsuit between Alnylam and partner Tekmira Pharmaceuticals (GSN 8/18/2011).

Alnylam also said that it has made improvements to its early-stage GalNAc conjugation technology for siRNA delivery

“Improvements in chemistry lead to markedly increased potency for in vivo target gene silencing with GalNAc-conjugated siRNAs administered by subcutaneous injection at low, clinically relevant doses,” Alnylam said.

Meanwhile, administration of GalNAc-conjugated siRNAs against transthyretin, the target of the firm's phase I transthyretin-mediated amyloidosis therapy ALN-TTR01, resulted in robust gene silencing in preclinical animal models with an ED50 of approximately 5 mg/kg after a single subcutaneous injection.

Earlier this year, Alnylam CEO John Maraganore called conjugate-based delivery approaches “the future for delivery of small interfering RNAs” (GSN 6/2/2011).

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.